Here is a list of our latest company presentations from ChromoGenics AB.
Presentations
Redeye Interview – May 28th, 2024
Redeye interviewed our CEO, Fredrik Fränding, about the latest quarterly report, the overall tough market and the bid from Färna Invest.
Redeye Interview – March 3rd, 2024
Redeye interviewed our CEO, Fredrik Fränding, about the latest rights issue, our new project with Skanska for Boverket and the current market situation.
Redeye Interview – December 4th, 2023
Redeye interviewed our CEO, Fredrik Fränding, discussing the company’s performance in the recent quarter. Our conversation covered topics such as new partnerships, order intake, and the latest installation of dynamic glass at a hospital in Athens, Greece.
Presentation at Redeye Investor Forum Online – October 19, 2023
Our CEO Fredrik Fränding presented at Redeye Investor Forum Online. Afterwards Redeye interviewed Fredrik.
Presentation of the Q2-report - August 26th, 2023
Redeye interviewed our CEO Fredrik Fränding after the release of the Q2 report. We talked about new partners, the tough market environment, improved production yield, and focus on costs.
Presentation of the Q1-report - May 26th, 2023
Redeye interviewed our CEO Fredrik Fränding after the release of the Q1’23 report. He talk about that ChromoGenics continuing adding strategic partners and the focus on sales activities and cost control. He also talk about the announced rights issue and the ongoing insurance claim related to the Gullhaug Torg 5 project in Oslo.
Presentation of the Q3-report - November 4th, 2022
Our CEO Fredrik Fränding presenting the Q3-report on November 4th, 2022. The presentation was held in Swedish.
Presentation of the Q2-report - August 25th, 2022
Our CEO Fredrik Fränding presenting the Q2-report on August 25th, 2022. The presentation was held in Swedish.
Presentation of the rights issue - February 17th, 2022
Our CEO Fredrik Fränding presenting about the rights issue with subscription period February 17 to March 3 on February 17th, 2022. The presentation was held in Swedish.
Presentation of Q4 and Year End Report for the financial year 2021 - February 9th, 2022
Our CEO Fredrik Fränding presenting of Q4 and Year End Report of the financial year 2021 on February 9th, 2022. The presentation was held in Swedish.
ProHearings Capital Markets Day - January 27th, 2022
Our CEO Fredrik Fränding presenting at ProHearings Capital Markets Day on January 27th, 2022. The presentation was held in Swedish.
Digitala Aktiekvällen - January 12th, 2022
Our CEO Fredrik Fränding presenting at Aktiespararna’s digital event Digitala Aktiekvällen on January 12th, 2022. The presentation was held in Swedish.
Redeye Technology Day - December 1st, 2021
Our CEO Fredrik Fränding presenting at Redeye Technology Day on December 1st, 2021.
Aktiedagen - September 7th, 2021
CEO Fredrik Fränding presenting at Aktiespararna’s digital event Aktiedagen on September 7th, 2022. The presentation was held in Swedish.
Latest posts
- Avnotering av ChromoGenics AB (publ) från Nasdaq First North Stockholm September 16, 2024
- ChromoGenics Interim Report January–June 2024 August 30, 2024
- ChromoGenics AB (publ): Bulletin from the annual general meeting held on 25 June 2024 June 25, 2024
- ChromoGenics AB (publ) publishes the Annual Report for 2023 June 18, 2024
- ChromoGenics announces a conditional loan of 47,6 MSEK is converted to a grant May 30, 2024
- NOTICE TO ANNUAL GENERAL MEETING IN CHROMOGENICS AB May 24, 2024